Robert Suttle, an advocate for the rights of those living with HIV, was sentenced to jail after a former partner accused him ...

The EU has given Gilead the green light to market its twice-yearly pre-exposure prophylaxis (PrEP) product lenacapavir, which ...

KENYA: KENYA has begun a yearlong study to examine why some patients on dolutegravir, the world’s leading HIV drug, are not ...

The obesity epidemic will hit South Africa hard on top of our high HIV burden, but advocate researcher and scientist Dr ...

The European Commission has granted marketing authorization for Gilead Sciences' twice-yearly injection for preventing HIV infection, the company said on Tuesday.

"No, because I am not afraid to die," Barkley told Sports Illustrated's Rick Reilly in 1992. "I have accomplished everything ...

Analysts and charities have identified Gilead’s new HIV prevention injection as key to curbing infection rates ...

Gilead Sciences (NASDAQ:GILD) announced on Tuesday that the European Commission granted marketing authorization for its ...

At the International AIDS Society meeting this year, a young woman from South Africa spoke. She is the first Black woman from ...

In the mid-1990s, clinicians treating people with HIV began to notice a syndrome characterized by loss of limb fat, facial ...

Funding will be cut by half for both this and next year’s federal budgets, before he shuts down the President’s Emergency ...

Guwahati: In a concerning shift, injecting drug use has become the predominant route of HIV transmission in Assam, accounting ...